Cargando…
Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis
Colon cancer is still the third most common cancer which has a high mortality but low five-year survival rate. Novel tyrosine kinase inhibitors (TKI) such as pazopanib become effective antineoplastic agents that show promising clinical activity in a variety of carcinoma, including colon cancer. Howe...
Autores principales: | Zhang, Lingling, Wang, Huanan, Li, Wei, Zhong, Juchang, Yu, Rongcheng, Huang, Xinfeng, Wang, Honghui, Tan, Zhikai, Wang, Jiangang, Zhang, Yingjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356882/ https://www.ncbi.nlm.nih.gov/pubmed/27924057 http://dx.doi.org/10.18632/oncotarget.13753 |
Ejemplares similares
-
Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA‐dependent apoptosis in colorectal cancer
por: Chen, Jingfei, et al.
Publicado: (2018) -
PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer
por: Wang, Huanan, et al.
Publicado: (2015) -
SIRT6 promotes autophagy through direct interaction with ULK1 and competitive binding to PUMA
por: Wu, Zhongguang, et al.
Publicado: (2022) -
Enhanced growth and differentiation of myoblast cells grown on E-jet 3D printed platforms
por: Chen, Haoxiang, et al.
Publicado: (2019) -
SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy
por: Zhang, Yingjie, et al.
Publicado: (2019)